UNIVERSAL T CELL-BASED, CMV-VECTORED VACCINE FOR INFLUENZA
Application
US20260091102A1
Kind: A1
Apr 02, 2026
Assignee
Oregon Health & Science University
Inventors
Jonah SACHA, Louis PICKER, Daniel MALOULI, Scott HANSEN, Klaus FRUEH
Abstract
The invention relates to methods of generating an immune response for the treatment or prevention of a pathogenic infection. The invention also relates to methods of generating MHC-I, MHC-II, and/or MHC-E restricted CD8+ and/or CD4+ T cells for the treatment or prevention of a pathogenic infection.
CPC Classifications
A61K 39/145
A61K 40/11
A61K 40/32
A61P 31/16
C07K 14/7051
C12N 5/0636
C12N 15/86
C12Q 1/6869
A61K 2039/5158
A61K 2039/525
A61K 2039/542
A61K 2039/57
C12N 2710/16143
Filing Date
2023-09-13
Application No.
19111143